NEW YORK (GenomeWeb News) – Siemens has put its lab-on-a-chip technology up for sale.
ICAP Patent Brokerage today announced the sale of Siemens' lab-on-a-chip technology patent portfolio of more than 200 assets, including 18 US patents. The technology can be used to detect DNA and RNA sequences using electrophoresis, SNP analysis, isolation of magnetic beads, and PCR thermocycling for sensory applications. It can also be used for extraction and analyzing a smear sample of complete DNA or protein with microfluidic systems.
In addition, it can be used to address the manufacturing of "cost-effective sensor arrangements" for use in medical diagnostics, environmental analysis, food analysis, and pharmacology, ICAP Patent Brokerage said.
ICAP Patent Brokerage is a division of ICAP and calls itself the world's largest IP brokerage and patent auction firm.
The technology that is up for sale won the German Future Prize in 2004 and was developed by Siemens, Fraunhofer Institute for Silicon Technology, and Infineon Technologies, a Siemens spinout. In 2005 Siemens took over development of the technology with the intent of bringing to market a biochip molecular diagnostic system called Quicklab for performing tests rapidly that incorporated the technology, as GenomeWeb Daily News' sister publication BioArray News reported at the time.